Fractalkine (FKN) and its receptor CX3CR1 are critical mediators in thevascular and tissue damage of several chronic diseases, including systemicsclerosis (SSc) and pulmonary arterial hypertension (PAH). Here, CX3CL1 is linked to pulmonary arterial hypertension.